LEAH BALCH: Open Payments
NPI 1225451925 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,731 in 121 payments from 23 companies in 2025. Trend: 2023 $975 · 2024 $2,176 · 2025 $3,731
Food & beverage: $2,163Speaker / faculty: $1,400Travel & lodging: $168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $1,974 |
| Neurelis, Inc. | 7 | $215 |
| Janssen Biotech, Inc. | 7 | $212 |
| UCB, Inc. | 8 | $198 |
| Gilead Sciences, Inc. | 17 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $159 |
| ARGENX US, INC. | 6 | $102 |
| Aimmune Therapeutics, Inc. | 5 | $94 |
| Ardelyx, Inc. | 5 | $81 |
| Lundbeck LLC | 4 | $79 |
Products named: CREON, VALTOCO, TREMFYA, MAVYRET, LINZESS, VYVGART, Briviact, ZENPEP.
Industry payments across TN — which companies pay providers there.
